TY - JOUR
T1 - Graded transthoracic contrast echocardiography after pulmonary arteriovenous malformation embolization
T2 - Can Chest CT Scan Be Avoided in Patients With a Low-Grade Shunt?
AU - Hessels, J
AU - Klompmaker, S
AU - van den Heuvel, D A F
AU - Boerman, S
AU - Mager, J J
AU - Post, M C
N1 - Publisher Copyright:
© 2024 American College of Chest Physicians
PY - 2025/3
Y1 - 2025/3
N2 - Background: Pulmonary arteriovenous malformations (PAVMs) are direct connections between the pulmonary artery and vein, creating a right-to-left shunt (RLS). Embolization is indicated to prevent complications. Guidelines recommend follow-up chest CT scans to confirm persistent occlusion and embolization of all treatable PAVMs. Graded transthoracic contrast echocardiography (TTCE) after PAVM embolization may offer a reliable alternative in a subgroup of patients while preventing radiation exposure. Research Question: Can TTCE predict the need for additional embolotherapy in the postembolization population as accurately as it does in the treatment-naive population? Study Design and Methods: Since 2018, follow-up after PAVM embolization at our study institution includes both TTCE and chest CT scan after 6 to 12 months and every 3 to 5 years thereafter. Patients who underwent at least 1 follow-up TTCE and chest CT scan were included. The indication for additional embolotherapy was discussed in a multidisciplinary team meeting. The primary outcome was the indication for additional embolotherapy in each right-to-left shunt (RLS) grade. Additionally, the association between the RLS grade and indication for additional embolotherapy was investigated. Results: A total of 339 patients with 412 embolization procedures were included; median time to follow-up TTCE was 7.5 months. An RLS was present in 399 postembolization TTCEs (97%): RLS grade 1 in 93 patients (23%), grade 2 in 149 patients (36%) and grade 3 in 157 patients (38%). In patients with RLS grades 0 and 1, no treatable PAVMs were found on CT scan. In patients with RLS grades 2 and 3, 22 (15%) and 72 (46%) underwent additional embolization. Interpretation: This study shows chest CT scan might be withheld in patients with RLS grades 0 and 1 after PAVM embolization.
AB - Background: Pulmonary arteriovenous malformations (PAVMs) are direct connections between the pulmonary artery and vein, creating a right-to-left shunt (RLS). Embolization is indicated to prevent complications. Guidelines recommend follow-up chest CT scans to confirm persistent occlusion and embolization of all treatable PAVMs. Graded transthoracic contrast echocardiography (TTCE) after PAVM embolization may offer a reliable alternative in a subgroup of patients while preventing radiation exposure. Research Question: Can TTCE predict the need for additional embolotherapy in the postembolization population as accurately as it does in the treatment-naive population? Study Design and Methods: Since 2018, follow-up after PAVM embolization at our study institution includes both TTCE and chest CT scan after 6 to 12 months and every 3 to 5 years thereafter. Patients who underwent at least 1 follow-up TTCE and chest CT scan were included. The indication for additional embolotherapy was discussed in a multidisciplinary team meeting. The primary outcome was the indication for additional embolotherapy in each right-to-left shunt (RLS) grade. Additionally, the association between the RLS grade and indication for additional embolotherapy was investigated. Results: A total of 339 patients with 412 embolization procedures were included; median time to follow-up TTCE was 7.5 months. An RLS was present in 399 postembolization TTCEs (97%): RLS grade 1 in 93 patients (23%), grade 2 in 149 patients (36%) and grade 3 in 157 patients (38%). In patients with RLS grades 0 and 1, no treatable PAVMs were found on CT scan. In patients with RLS grades 2 and 3, 22 (15%) and 72 (46%) underwent additional embolization. Interpretation: This study shows chest CT scan might be withheld in patients with RLS grades 0 and 1 after PAVM embolization.
KW - Rendu-Osler-Weber
KW - contrast ultrasound
KW - echo bubble
KW - embolotherapy
KW - hereditary hemorrhagic telangiectasia
KW - pulmonary arteriovenous malformation
KW - pulmonary right-to-left shunt
KW - transthoracic contrast echocardiography
UR - http://www.scopus.com/inward/record.url?scp=85216461403&partnerID=8YFLogxK
U2 - 10.1016/j.chest.2024.09.029
DO - 10.1016/j.chest.2024.09.029
M3 - Article
C2 - 39384101
SN - 0012-3692
VL - 167
SP - 842
EP - 850
JO - Chest
JF - Chest
IS - 3
ER -